As 2024 draws to a close, Sonio reflects on a year defined by great advancements, strategic partnerships, and significant milestones. From expanding our footprint in the U.S.A and Europe to strengthening our leadership team and product offerings, Sonio has continued to redefine the landscape of prenatal ultrasound.
As 2024 draws to a close, Sonio reflects on a year defined by great advancements, strategic partnerships, and significant milestones. From expanding our footprint in the U.S.A and Europe to strengthening our leadership team and product offerings, Sonio has continued to redefine the landscape of prenatal ultrasound. Here's a look back at our key highlights.
Our official launch in the U.S. was unveiled at SMFM 2024 (Society for Maternal-Fetal Medicine) in February. This pivotal event showcased Sonio’s cutting-edge ultrasound reporting solution and emphasized our readiness to empower healthcare providers with efficient, AI-enhanced screening tools.
Beyond SMFM, Sonio expanded its global footprint at key events:
Pediatrix Medical Group, a leading provider specialized in women’s health, children, and babies in the U.S., was among the first to adopt Sonio’s technology. Their decision underscores a shared commitment to advancing prenatal care through innovative tools, paving the way for progress in specialized healthcare.
This collaboration highlights how AI-powered solutions can support clinicians in improving outcomes for patients. We’re excited to explore this further at SMFM, where Dr. Andrew Combs will discuss the impact of Sonio’s technology and its potential to enhance clinical practice.
One of the most transformative moments this year was Sonio’s acquisition by Samsung Healthcare. While Sonio will continue to operate independently, this partnership allows us to combine our strengths with Samsung Healthcare’s expertise to accelerate our shared vision. Together, we are set to redefine the future of maternal-fetal medicine by delivering unparalleled diagnostic solutions. Importantly, Sonio’s platform will remain vendor-agnostic—compatible with all ultrasound systems—ensuring healthcare providers retain the freedom to choose their preferred devices while leveraging our advanced AI capabilities.
Explore details of the acquisition here.
This year has been a milestone for Sonio as we experienced incredible growth, doubling our team size from 35 to 70 talented individuals worldwide. This growth reflects our commitment to innovation and our mission to deliver high-quality prenatal care solutions globally.
With this expansion, we’ve enhanced our capabilities by welcoming new talent and collaborating with industry-leading experts.
Follow our LinkedIn page for our latest job opportunities and news
Innovation remains at the core of Sonio’s mission. This year, we achieve regulatory milestones and product updates:
Sonio’s journey in 2024 has been nothing short of inspiring. Our advancements, partnerships, and innovations have set the stage for even greater achievements in the years ahead.
As we look to 2025, we remain focused on our vision. Starting at SMFM, we’re thrilled to launch our next product, which promises to further revolutionize prenatal care by addressing clinicians' needs and enhancing patient outcomes. We’ll continue to grow, adapt, and innovate with our partners for a healthier future.
At the heart of everything we do is a commitment to improving women’s and children’s health by promoting access and quality of care through technological innovation, medical expertise, and collective intelligence. By combining cutting-edge technology with a patient-centered approach, we aim to make prenatal care more precise, accessible, and impactful.
Here’s to a future of limitless possibilities. Together, we’ll keep building, innovating, and achieving. Thank you for being a part of Sonio’s remarkable journey.
Contact us and discover Sonio, the next-generation of Prenatal Ultrasounds.
